Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, updating the page version label.
    Difference
    0.0%
    Check dated 2026-01-14T03:44:41.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating sites by state (Arizona, Arkansas, California, Colorado, Florida, Louisiana, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas) and removed the previous per-state location subsections. This update improves visibility of where the study is conducted.
    Difference
    1%
    Check dated 2025-12-23T21:15:14.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing the prior v3.2.0. Other visible content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:36:05.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The funding/status notice at the bottom of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:51:43.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Results have been posted on 2025-07-14 and study record dates (First Submitted, Last Update, Primary Completion, Study Completion) have been updated. This update clarifies the current status and available outcome information for the trial.
    Difference
    0.4%
    Check dated 2025-11-03T20:50:45.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:57:39.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.